Eli Lilly soars 14% after upbeat earnings



Eli Lilly and Company soared more than 14% in Tuesday’s trading after it reported better-than-expected results for the second quarter.

The pharmaceutical company said its revenue climbed 28% year…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento